Myotonic Dystrophies Type 1 and 2: A Summary on Current Aspects

Seminars in Pediatric Neurology

Volumn 13, Issue 2, 2006, Pages 71-79

  Schara, Ulrike ^a   Schoser, Benedikt G H ^b  

^a Neuss City Hospital   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

congenital DM; DM1; DM2; myotonic dystrophy; PROMM

Indexed keywords

ANTIDIABETIC AGENT; CARBAMAZEPINE; CREATINE KINASE; GAMMA GLUTAMYLTRANSFERASE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; METFORMIN; MEXILETINE; PHENYTOIN; THYROXINE;

ARTICLE; AUTOSOMAL DOMINANT DISORDER; BLOOD DISEASE; CATARACT; CHILDHOOD DISEASE; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; ELECTROMYOGRAPHY; GENE MUTATION; GENETIC DIFFERENCE; GENETIC VARIABILITY; HEART MUSCLE CONDUCTION DISTURBANCE; HORMONE DEFICIENCY; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; MENTAL DEFICIENCY; MOLECULAR GENETICS; MOTOR DYSFUNCTION; MUSCULAR DYSTROPHY; MYOTONIA; MYOTONIC DYSTROPHY; MYOTONIC DYSTROPHY TYPE 1; MYOTONIC DYSTROPHY TYPE 2; NEUROPATHOLOGY; ONSET AGE; PALLIATIVE THERAPY; PATHOGENESIS; PATIENT MONITORING; PHYSIOTHERAPY; PSYCHIATRIC TREATMENT; PTOSIS; RESPIRATORY FUNCTION; RNA METABOLISM; STILLBIRTH; TREATMENT INDICATION; TREATMENT PLANNING;

CREATINE KINASE; GAMMA-GLUTAMYLTRANSFERASE; IMMUNOGLOBULINS; MYOTONIC DYSTROPHY; RNA-BINDING PROTEINS; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 33749261633     PISSN: 10719091     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.spen.2006.06.002     Document Type: Article

References (42)

1. Steinert H. Myopathologische Beiträge 1. Über das klinische und anatomische Bild des Muskelschwunds der Myotoniker. Dtsch Zeitschr Nervenheilk 37 (1909) 58-104
2. Batten F.E., and Gibb H.P. Myotonia atrophica. Brain 32 (1909) 187-205
3. Harper P.S. Major problems in neurology, in Myotonic Dystrophy. ed 3 (2001), Saunders, Philadelphia, PA
4. Harper P.S., and Monckton D.G. Myotonic dystrophy. In: Engel A.G., and Franzini-Armstrong C. (Eds). Myology. ed 3 (2004), McGraw Hill Professional, New York, NY 1039-1076
5. Curschmann H. Über familiäre atrophische Myotonie. Dtsch Zeitschr Nervenheilk 45 (1912) 161-202
6. Curschmann H. Myotonische Dystrophie (atrophische myotonie). In: Bumke O., and Förster O. (Eds). Handbuch der Neurologie (1936), Springer Verlag, Berlin 465-485
7. Fleischer B. Über myotonische Dystrophie mit Katarakt. Graefes Arch Klin Ophthalmol 96 (1918) 91-133
8. Ricker K., Koch M.C., Lehmann-Horn F., et al. Proximal myotonic myopathy: A new dominant disorder with myotonia, muscle weakness, and cataracts. Neurology 44 (1994) 1448-1452
9. Thornton C.A., Griggs R.C., and Moxley III R.T. Myotonic dystrophy with no trinucleotide repeat expansion. Ann Neurol 35 (1994) 269-272
10. Udd B., Krahe R., Wallgren-Pettersson C., Falck B., et al. Proximal myotonic dystrophy-A family with autosomal dominant muscular dystrophy, cataracts, hearing loss and hypogonadism: Heterogeneity of proximal myotonic syndromes?. Neuromuscul Disord 7 (1997) 217-228
11. Day J.W., Roelofs R., Leroy B., et al. Clinical and genetic characteristics of a five-generation family with a novel form of myotonic dystrophy (DM2). Neuromuscul Disord 9 (1999) 19-27
12. Aslanidis C., Jansen G., Amemiya C., et al. Cloning of the essential myotonic dystrophy region and mapping of the putative defect. Nature 355 (1992) 548-551
13. Buxton J., Shelbourne P., Davies J., et al. Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature 355 (1992) 547-548
14. Harley H.G., Brook J.D., Rundle S.A., et al. Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature 355 (1992) 545-546
15. Mahadevan M., Tsilfidis C., Sabourin L., et al. Myotonic dystrophy mutation: An unstable CTG repeat in the 3′ untranslated region of the gene. Science 255 (1992) 1253-1255
16. Day J.W., and Ranum L.P. RNA pathogenesis of the myotonic dystrophies. Neuromuscul Disord 15 (2005) 5-16
17. Ranum L.P., Rasmussen P.F., Benzow K.A., et al. Genetic mapping of a second myotonic dystrophy locus. Nat Genet 19 (1998) 196-198
18. Liquori C.L., Ricker K., Moseley M.L., et al. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 293 (2001) 864-867
19. Bachinski L.L., Udd B., Meola G., et al. Confirmation of DM2 (CCTG)n expansion mutation in PROMM/PDM patients of different European origins: A single shared haplotype indicates ancestral founder effects. Am J Hum Genet 73 (2003) 835-848
20. Liquori C.L., Ikeda Y., Weatherspoon M., et al. Myotonic dystrophy type 2: Human founder haplotype and evolutionary conservation of the repeat tract. Am J Hum Genet 73 (2003) 849-862
21. Schoser B.G.H., Kress W., Walter M.C., et al. Homozygosity for CCTG mutation in myotonic dystrophy type 2. Brain 127 (2004) 1868-1877
22. Day J.W., Ricker K., Jacobson J.F., et al. Myotonic dystrophy type 2. Neurology 60 (2003) 657-664
23. Machuca-Tzili L., Brook D., and Hilton-Jones D. Clinical and molecular aspects of the myotonic dystrophies: A review. Muscle Nerve 32 (2005) 1-18
24. Ho T.H., Bundman D., Armstrong D.L., and Cooper T.A. Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy. Am J Hum Genet 14 (2005) 1539-1547
25. Schara U., and Mortier W. Neuromuskuläre Erkrankungen (NME): Teil 2: Muskeldystrophien (MD). Nervenarzt 75 (2004) 219-239
26. Vanier T.M. Dystrophia myotonica in childhood. Br Med J 2 (1960) 1284-1288
27. Rutherford M.A., Heckmatt J.Z., and Dubowitz V. Congenital myotonic dystrophy: Respiratory function at birth determines survival. Arch Dis Child 64 (1989) 191-195
28. Rais-Bahrami K., MacDonald M.G., Eng G.D., et al. Persistent pulmonary hypertension in newborn infants with congenital myotonic dystrophy. J Pediatr 124 (1994) 634-635
29. Joseph J.T., Richards C.S., Anthony D.C., et al. Congenital myotonic dystrophy: Pathology and somatic mosaicism. Neurology 49 (1997) 1457-1460
30. Bassez G., Lazarus A., Desguerre I., et al. Severe cardiac arrhythmias in young patients with myotonic dystrophy type 1. Neurology 63 (2004) 1939-1941
31. De-Smulders C. Long-term clinical and genetic studies in myotonic dystrophy (thesis) (2000), University of Maastricht, The Netherlands
32. Le Ber I., Martinez M., Campion D., et al. A non-DM1, non-DM2 multisystem myotonic disorder with frontotemporal dementia: Phenotype and suggestive mapping of the DM2 locus to chromosome 15q21-24. Brain 127 (2004) 1979-1992
33. Rudnik-Schöneborn S., Schneider-Gold C., Raabe U., et al. Pregnancy and delivery in myotonic dystrophy type 2: A retrospective study of 42 patients. Neurology 66 (2006) 579-580
34. Meola G., and Moxley III R.T. Myotonic dystrophy type 2 and related myotonic disorders. J Neurol 251 (2005) 1173-1182
35. Schoser B.G.H., Ricker K., Schneider-Gold C., et al. Sudden death in myotonic dystrophy type 2. Neurology 63 (2004) 966-967
36. Mankodi A., Lin X., Blaxall B.C., et al. Nuclear RNA foci in heart in myotonic dystrophy. Circ Res 97 (2005) 1152-1155
37. Maurage C.A., Udd B., Ruchoux M.M., et al. Similar brain tau pathology in DM2/PROMM and DM1/Steinert disease. Neurology 65 (2005) 1636-1638
38. Schoser B.G.H., Schneider-Gold C., Reilich P., et al. Muscle pathology in 57 patients with myotonic dystrophy type 2. Muscle Nerve 29 (2004) 275-281
39. van Engelen B.G., Eymard B., and Wilcox D. 123rd ENMC international workshop: Management and Therapy in Myotonic Dystrophy, 6-8 February 2004, Naarden, The Netherlands. Neuromuscul Disord 15 (2005) 389-394
40. Kurihara T. New classification and treatment for myotonic disorders. Intern Med 44 (2005) 1027-1032
41. van der Kooi E.L., Lindeman E., and Riphagen I. Strength training and aerobic exercise training for muscle disease (review). Cochrane Database Syst Rev 1 (2005) CD003907
42. Udd B., Meola G., Krahe R., et al. 140th ENMC International Workshop: Myotonic Dystrophy DM2/PROMM and other myotonic dystrophies with guidelines on management. Neuromuscul Disord 16 (2006) 403-413